A comparative transcriptomic study between psoriasis patients and healthy controls has demonstrated the elevated expression of PANoptotic activators including absent in melanoma-2 (AIM2) and interferon regulatory factor 1 (IRF1) [95]. Here, AIM2 is linked to psoriasis.